Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

Artificial ascites for organs at risk sparing in intrapelvic brachytherapy: a case report of recurrent uterine cervical carcinoma adjacent to the bowel.

Murakami N, Shima S, Okuma K, Iijima K, Tselis N, Uematsu M, Takagawa Y, Kashihara T, Masui K, Yoshida K, Takahashi K, Inaba K, Igaki H, Nakayama Y, Itami J.

BJR Case Rep. 2018 Aug 11;5(1):20180067. doi: 10.1259/bjrcr.20180067. eCollection 2019 Feb.

2.

Dose escalation of external beam radiotherapy for high-risk prostate cancer-Impact of multiple high-risk factor.

Umezawa R, Inaba K, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Takahashi K, Murakami N, Ito Y, Igaki H, Jingu K, Itami J.

Asian J Urol. 2019 Apr;6(2):192-199. doi: 10.1016/j.ajur.2017.07.002. Epub 2017 Oct 19.

3.

Hyaluronate gel injection for rectum dose reduction in gynecologic high-dose-rate brachytherapy: initial Japanese experience.

Kashihara T, Murakami N, Tselis N, Kobayashi K, Tsuchida K, Shima S, Masui K, Yoshida K, Takahashi K, Inaba K, Umezawa R, Igaki H, Ito Y, Kato T, Uno T, Itami J.

J Radiat Res. 2019 Apr 29. pii: rrz016. doi: 10.1093/jrr/rrz016. [Epub ahead of print]

PMID:
31034570
4.

Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy for unresectable sinonasal undifferentiated carcinoma: Two cases of report.

Watanabe S, Honma Y, Murakami N, Igaki H, Mori T, Hirano H, Okita N, Shoji H, Iwasa S, Takashima A, Kato K, Kobayashi K, Matsumoto F, Yoshimoto S, Itami J, Boku N.

World J Clin Cases. 2019 Mar 26;7(6):765-772. doi: 10.12998/wjcc.v7.i6.765.

5.

Hyaluronic gel injection into the vesicovaginal septum for high-dose-rate brachytherapy of uterine cervical cancer: an effective approach for bladder dose reduction.

Murakami N, Shima S, Kashihara T, Tselis N, Kato T, Takagawa Y, Masui K, Yoshida K, Takahashi K, Inaba K, Okuma K, Igaki H, Nakayama Y, Itami J.

J Contemp Brachytherapy. 2019 Feb;11(1):1-7. doi: 10.5114/jcb.2019.82612. Epub 2019 Jan 29.

6.

A hybrid technique of intracavitary and interstitial brachytherapy for locally advanced cervical cancer: initial outcomes of a single-institute experience.

Murakami N, Kobayashi K, Shima S, Tsuchida K, Kashihara T, Tselis N, Umezawa R, Takahashi K, Inaba K, Ito Y, Igaki H, Nakayama Y, Masui K, Yoshida K, Kato T, Itami J.

BMC Cancer. 2019 Mar 12;19(1):221. doi: 10.1186/s12885-019-5430-x.

7.

[On-line Adaptive Radiotherapy Using MRI-Guided Technique].

Okamoto H, Sakasai T, Nishioka S, Miura Y, Aikawa A, Kuwahara J, Iijima K, Abe Y, Igaki H, Itami J.

Igaku Butsuri. 2019;38(4):159-165. doi: 10.11323/jjmp.38.4_159. Japanese.

8.

Hemorrhage from Ascending Colon and Gluteal Muscle Associated with Sorafenib and Radiation Therapy: Radiation Dose Distribution Corresponded with Colonoscopy Findings and Computed Tomography Images.

Kashihara T, Murakami N, Iizumi S, Sakamoto Y, Nakamura S, Iijima K, Takahashi K, Inaba K, Okuma K, Igaki H, Nakayama Y, Okusaka T, Uno T, Itami J.

Pract Radiat Oncol. 2019 Feb 27. pii: S1879-8500(19)30066-9. doi: 10.1016/j.prro.2019.02.012. [Epub ahead of print] No abstract available.

PMID:
30825665
9.

Dependence of neutrons generated by 7Li(p,n) reaction on Li thickness under free-air condition in accelerator-based boron neutron capture therapy system employing solid-state Li target.

Nakamura S, Igaki H, Okamoto H, Wakita A, Ito M, Imamichi S, Nishioka S, Iijima K, Nakayama H, Takemori M, Kobayashi K, Abe Y, Okuma K, Takahashi K, Inaba K, Murakami N, Nakayama Y, Nishio T, Masutani M, Itami J.

Phys Med. 2019 Feb;58:121-130. doi: 10.1016/j.ejmp.2019.02.010. Epub 2019 Feb 16.

PMID:
30824143
10.

Efficacy of preserving the residual stomach in esophageal cancer patients with previous gastrectomy.

Nakanishi K, Daiko H, Kato F, Kanamori J, Igaki H, Tachimori Y, Koyanagi K.

Gen Thorac Cardiovasc Surg. 2019 May;67(5):470-478. doi: 10.1007/s11748-019-01070-1. Epub 2019 Feb 18.

PMID:
30778905
11.

Inferior vena cava syndrome caused by retroperitoneal fibrosis after pelvic irradiation: A case report.

Murakami N, Arai Y, Takagawa Y, Okuma K, Takahashi K, Inaba K, Igaki H, Nakayama Y, Itami J.

Gynecol Oncol Rep. 2018 Dec 4;27:19-21. doi: 10.1016/j.gore.2018.12.002. eCollection 2019 Feb.

12.

Dose coverage comparison between "interstitial catheter-only" and "hybrid intracavitary-interstitial brachytherapy" for early stage squamous cell carcinoma of the buccal mucosa.

Murakami N, Ueno T, Yatsuoka W, Okamoto H, Tselis N, Masui K, Yoshida K, Takahashi K, Inaba K, Okuma K, Igaki H, Nakayama Y, Itami J.

J Contemp Brachytherapy. 2018 Oct;10(5):486-491. doi: 10.5114/jcb.2018.79471. Epub 2018 Oct 31.

13.

Monte Carlo modeling of a 60Co MRI-guided radiotherapy system on Geant4 and experimental verification of dose calculation under a magnetic field of 0.35 T.

Okamoto H, Nishioka S, Iijima K, Nakamura S, Sakasai T, Miura Y, Takemori M, Nakayama H, Morishita Y, Shimizu M, Abe Y, Igaki H, Nakayama Y, Itami J.

J Radiat Res. 2019 Jan 1;60(1):116-123. doi: 10.1093/jrr/rry087.

14.

[Efforts toward Patient Safety: Development of System and Education of Non-Technical Skill].

Okamoto H, Nakamura S, Nishioka S, Iijima K, Takemori M, Nakayama H, Aikawa A, Shibata Y, Kato T, Abe Y, Igaki H, Nakayama Y, Itami J.

Igaku Butsuri. 2018;38(2):62-67. doi: 10.11323/jjmp.38.2_62. Japanese.

15.

Intrafraction esophageal motion in patients with clinical T1N0 esophageal cancer.

Sekii S, Ito Y, Harada K, Kitaguchi M, Takahashi K, Inaba K, Murakami N, Igaki H, Sasaki R, Itami J.

Rep Pract Oncol Radiother. 2018 Sep-Oct;23(5):398-401. doi: 10.1016/j.rpor.2018.07.013. Epub 2018 Aug 13.

PMID:
30127681
16.

Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.

Hashimoto J, Kato K, Ito Y, Kojima T, Akimoto T, Daiko H, Hamamoto Y, Matsushita H, Katano S, Hara H, Tanaka Y, Saito Y, Nagashima K, Igaki H.

Int J Clin Oncol. 2019 Jan;24(1):60-67. doi: 10.1007/s10147-018-1336-x. Epub 2018 Aug 14.

PMID:
30109544
17.

Long-term outcome after resection for recurrent oesophageal cancer.

Kato F, Monma S, Koyanagi K, Kanamori J, Daiko H, Igaki H, Tachimori Y.

J Thorac Dis. 2018 May;10(5):2691-2699. doi: 10.21037/jtd.2018.05.17.

18.

Present clinical practices of stereotactic irradiation for metastatic brain tumors in Japan: results of questionnaire survey of the Japanese Radiation Oncology Study Group (JROSG) working subgroup for neurological tumors.

Harada K, Igaki H, Abe E, Ariga T, Hayashi N, Kanemoto A, Komiyama T, Matsumoto Y, Nakano T, Onimaru R, Saito H, Sumi M, Tago M, Tanaka K, Maebayashi K, Aoyama H; Japanese Radiation Oncology Study Group (JROSG) Working Subgroup for Neurological Tumors.

Int J Clin Oncol. 2018 Dec;23(6):1015-1022. doi: 10.1007/s10147-018-1313-4. Epub 2018 Jul 3.

PMID:
29971621
19.

Long-term Results of External Beam Radiotherapy for Prostate Cancer with Prostate-specific Antigen of More Than 50 ng/ml and Without Evidence of Lymph Node or Distant Metastasis.

Umezawa R, Inaba K, Nakamura S, Wakita A, Okamoto H, Shima S, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Takahashi K, Murakami N, Ito Y, Igaki H, Jingu K, Itami J.

Anticancer Res. 2018 Apr;38(4):2303-2309.

PMID:
29599353
20.

Importance of the site of positive surgical margin in salvage external beam radiation therapy for biochemical recurrence of prostate cancer after radical prostatectomy.

Kashihara T, Nakamura S, Wakita A, Okamoto H, Inaba K, Umezawa R, Shima S, Tsuchida K, Kobayashi K, Takahashi K, Murakami N, Ito Y, Igaki H, Fujimoto H, Uno T, Itami J.

Cancer Med. 2018 May;7(5):1723-1730. doi: 10.1002/cam4.1408. Epub 2018 Mar 23.

21.

Surgery with curative intent is associated with prolonged survival in patients with cutaneous angiosarcoma of the scalp and face -a retrospective study of 38 untreated cases in the Japanese population.

Oashi K, Namikawa K, Tsutsumida A, Takahashi A, Itami J, Igaki H, Inaba K, Yamazaki N.

Eur J Surg Oncol. 2018 Jun;44(6):823-829. doi: 10.1016/j.ejso.2018.02.246. Epub 2018 Mar 6.

PMID:
29555155
22.
23.

Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study.

Umezawa R, Murakami N, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Takahashi K, Inaba K, Ito Y, Igaki H, Masui K, Yoshida K, Jingu K, Tselis N, Itami J.

Brachytherapy. 2018 Mar - Apr;17(2):368-376. doi: 10.1016/j.brachy.2017.11.011. Epub 2017 Dec 21.

PMID:
29275869
24.

Evaluation of radioactivity in the bodies of mice induced by neutron exposure from an epi-thermal neutron source of an accelerator-based boron neutron capture therapy system.

Nakamura S, Imamichi S, Masumoto K, Ito M, Wakita A, Okamoto H, Nishioka S, Iijima K, Kobayashi K, Abe Y, Igaki H, Kurita K, Nishio T, Masutani M, Itami J.

Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(10):821-831. doi: 10.2183/pjab.93.051.

25.

Tumor location is a risk factor for lymph node metastasis in superficial Barrett's adenocarcinoma.

Yamada M, Oda I, Tanaka H, Abe S, Nonaka S, Suzuki H, Yoshinaga S, Kuchiba A, Koyanagi K, Igaki H, Taniguchi H, Sekine S, Saito Y, Tachimori Y.

Endosc Int Open. 2017 Sep;5(9):E868-E874. doi: 10.1055/s-0043-115388. Epub 2017 Sep 12.

26.

A systematic review of publications on charged particle therapy for hepatocellular carcinoma.

Igaki H, Mizumoto M, Okumura T, Hasegawa K, Kokudo N, Sakurai H.

Int J Clin Oncol. 2018 Jun;23(3):423-433. doi: 10.1007/s10147-017-1190-2. Epub 2017 Sep 4.

PMID:
28871342
27.

Detection of residual metastatic tumor in the brain following Gamma Knife radiosurgery using a single or a series of magnetic resonance imaging scans: An autopsy study.

Sakuramachi M, Igaki H, Ikemura M, Yamashita H, Okuma K, Sekiya N, Hayakawa Y, Sakumi A, Takahashi W, Hasegawa H, Fukayama M, Nakagawa K.

Oncol Lett. 2017 Aug;14(2):2033-2040. doi: 10.3892/ol.2017.6359. Epub 2017 Jun 9.

28.

Impact of laparoscopy on the prevention of pulmonary complications after thoracoscopic esophagectomy using data from JCOG0502: a prospective multicenter study.

Nozaki I, Mizusawa J, Kato K, Igaki H, Ito Y, Daiko H, Yano M, Udagawa H, Nakagawa S, Takagi M, Kitagawa Y.

Surg Endosc. 2018 Feb;32(2):651-659. doi: 10.1007/s00464-017-5716-5. Epub 2017 Aug 4.

29.

Outcomes of salvage high-dose-rate brachytherapy with or without external beam radiotherapy for isolated vaginal recurrence of endometrial cancer.

Sekii S, Murakami N, Kato T, Harada K, Kitaguchi M, Takahashi K, Inaba K, Igaki H, Ito Y, Sasaki R, Itami J.

J Contemp Brachytherapy. 2017 Jun;9(3):209-215. doi: 10.5114/jcb.2017.67755. Epub 2017 May 18.

30.

Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303).

Okuno T, Wakabayashi M, Kato K, Shinoda M, Katayama H, Igaki H, Tsubosa Y, Kojima T, Okabe H, Kimura Y, Kawano T, Kosugi S, Toh Y, Kato H, Nakamura K, Fukuda H, Ishikura S, Ando N, Kitagawa Y; Japan Esophageal Oncology Group/Japan Clinical Oncology Group.

Int J Clin Oncol. 2017 Dec;22(6):1042-1049. doi: 10.1007/s10147-017-1154-6. Epub 2017 Jul 17.

31.

Clinical Outcomes of Resectable Esophageal Cancer with Supraclavicular Lymph Node Metastases Treated with Curative Intent.

Honma Y, Hokamura N, Nagashima K, Sudo K, Shoji H, Iwasa S, Takashima A, Kato K, Hamaguchi T, Boku N, Umezawa R, Ito Y, Itami J, Koyanagi K, Igaki H, Tachimori Y.

Anticancer Res. 2017 Jul;37(7):3741-3749.

PMID:
28668869
32.

Outcomes of surgery followed by local brain radiotherapy compared with surgery followed by whole brain radiotherapy for single brain metastasis.

Igaki H, Harada K, Umezawa R, Miyakita Y, Ohno M, Takahashi M, Sumi M, Inaba K, Murakami N, Ito Y, Narita Y, Itami J.

Tumori. 2017 Jul 31;103(4):367-373. doi: 10.5301/tj.5000657. Epub 2017 Jun 27.

PMID:
28665470
33.

Modeling the detection efficiency of an HP-Ge detector for use in boron neutron capture therapy.

Nakamura S, Wakita A, Ito M, Okamoto H, Nishioka S, Iijima K, Kobayashi K, Nishio T, Igaki H, Itami J.

Appl Radiat Isot. 2017 Jul;125:80-85. doi: 10.1016/j.apradiso.2017.03.027. Epub 2017 Apr 2.

PMID:
28414991
34.

Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for overall survival in patients with clinical Stage II/III esophageal squamous cell carcinoma (JCOG1406-A).

Nomura M, Kato K, Ando N, Ohtsu A, Muro K, Igaki H, Abe T, Takeuchi H, Daiko H, Gotoh M, Kataoka K, Wakabayashi M, Kitagawa Y.

Jpn J Clin Oncol. 2017 Jun 1;47(6):480-486. doi: 10.1093/jjco/hyx040.

PMID:
28334858
35.

Effective treatment of empyema with bronchopleural fistula after esophagectomy by endobronchial embolization using endobronchial Watanabe Spigots.

Uchida S, Igaki H, Izumo T, Tachimori Y.

Int J Surg Case Rep. 2017;33:1-3. doi: 10.1016/j.ijscr.2016.11.025. Epub 2017 Jan 24.

36.

Radiation absorbed dose estimates for 18F-BPA PET.

Kono Y, Kurihara H, Kawamoto H, Yasui N, Honda N, Igaki H, Itami J.

Acta Radiol. 2017 Sep;58(9):1094-1100. doi: 10.1177/0284185116688378. Epub 2017 Jan 19.

PMID:
28103709
37.

The role of interstitial brachytherapy in the management of primary radiation therapy for uterine cervical cancer.

Murakami N, Kobayashi K, Kato T, Nakamura S, Wakita A, Okamoto H, Shima S, Tsuchida K, Kashihara T, Harada K, Takahashi K, Umezawa R, Inaba K, Ito Y, Igaki H, Itami J.

J Contemp Brachytherapy. 2016 Oct;8(5):391-398. Epub 2016 Oct 10.

38.

A management method for the statistical results of patient-specific quality assurance for intensity-modulated radiation therapy.

Nakamura S, Okamoto H, Wakita A, Umezawa R, Takahashi K, Inaba K, Murakami N, Kato T, Igaki H, Ito Y, Abe Y, Itami J.

J Radiat Res. 2017 Jul 1;58(4):572-578. doi: 10.1093/jrr/rrw107.

39.
40.

The Prevalence of Overall and Initial Lymph Node Metastases in Clinical T1N0 Thoracic Esophageal Cancer: From the Results of JCOG0502, a Prospective Multicenter Study.

Akutsu Y, Kato K, Igaki H, Ito Y, Nozaki I, Daiko H, Yano M, Udagawa H, Nakagawa S, Takagi M, Mizusawa J, Kitagawa Y.

Ann Surg. 2016 Dec;264(6):1009-1015.

PMID:
27420375
41.

In vivo spatial correlation between (18)F-BPA and (18)F-FDG uptakes in head and neck cancer.

Kobayashi K, Kurihara H, Watanabe Y, Murakami N, Inaba K, Nakamura S, Wakita A, Okamoto H, Umezawa R, Takahashi K, Igaki H, Ito Y, Yoshimoto S, Shigematsu N, Itami J.

Appl Radiat Isot. 2016 Sep;115:138-146. doi: 10.1016/j.apradiso.2016.05.026. Epub 2016 May 28.

42.

Long-term observations of radiation-induced creatinine clearance reduction and renal parenchymal volume atrophy.

Inaba K, Okamoto H, Wakita A, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Umezawa R, Takahashi K, Murakami N, Ito Y, Igaki H, Uno T, Itami J.

Radiother Oncol. 2016 Jul;120(1):145-9. doi: 10.1016/j.radonc.2016.04.022. Epub 2016 Jun 29.

PMID:
27372224
43.

Prognostic Impact of Postoperative Morbidity After Esophagectomy for Esophageal Cancer: Exploratory Analysis of JCOG9907.

Kataoka K, Takeuchi H, Mizusawa J, Igaki H, Ozawa S, Abe T, Nakamura K, Kato K, Ando N, Kitagawa Y.

Ann Surg. 2017 Jun;265(6):1152-1157. doi: 10.1097/SLA.0000000000001828.

PMID:
27280509
44.

Erratum: A total EQD2 greater than 85 Gy for trachea and main bronchus D2cc being associated with severe late complications after definitive endobronchial brachytherapy.

Murakami N, Kobayashi K, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Harada K, Yamada M, Sekii S, Takahashi K, Umezawa R, Inaba K, Ito Y, Igaki H, Itami J.

J Contemp Brachytherapy. 2016 Apr;8(2):164. doi: 10.5114/jcb.2016.59694. Epub 2016 Apr 29.

45.

Dose reconstruction technique using non-rigid registration to evaluate spatial correspondence between high-dose region and late radiation toxicity: a case of tracheobronchial stenosis after external beam radiotherapy combined with endotracheal brachytherapy for tracheal cancer.

Kobayashi K, Murakami N, Inaba K, Wakita A, Nakamura S, Okamoto H, Sato J, Umezawa R, Takahashi K, Igaki H, Ito Y, Shigematsu N, Itami J.

J Contemp Brachytherapy. 2016 Apr;8(2):156-63. doi: 10.5114/jcb.2016.59688. Epub 2016 Apr 29.

46.

Risk Factors for Esophageal Fistula Associated With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Cancer: A Supplementary Analysis of JCOG0303.

Tsushima T, Mizusawa J, Sudo K, Honma Y, Kato K, Igaki H, Tsubosa Y, Shinoda M, Nakamura K, Fukuda H, Kitagawa Y; Japan Esophageal Oncology Group of Japan Clinical Oncology Group (JCOG).

Medicine (Baltimore). 2016 May;95(20):e3699. doi: 10.1097/MD.0000000000003699.

47.

After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancer.

Nakamura S, Murakami N, Inaba K, Wakita A, Kobayashi K, Takahashi K, Okamoto H, Umezawa R, Morota M, Sumi M, Igaki H, Ito Y, Itami J.

BMC Cancer. 2016 May 3;16:296. doi: 10.1186/s12885-016-2329-7.

48.

Salvage High-dose-rate Interstitial Brachytherapy for Pelvic Recurrent Cervical Carcinoma After Hysterectomy.

Murakami N, Kato T, Miyamoto Y, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Takahashi K, Umezawa R, Inaba K, Ito Y, Igaki H, Itami J.

Anticancer Res. 2016 May;36(5):2413-21.

PMID:
27127151
49.

Risk Reduction of Cerebral Stroke After Stereotactic Radiosurgery for Small Unruptured Brain Arteriovenous Malformations.

Hanakita S, Shin M, Koga T, Igaki H, Saito N.

Stroke. 2016 May;47(5):1247-52. doi: 10.1161/STROKEAHA.116.013132. Epub 2016 Apr 12.

PMID:
27073242
50.

Log-file analysis of accuracy of beam localization for brain tumor treatment by CyberKnife.

Okamoto H, Hamada M, Sakamoto E, Wakita A, Nakamura S, Kato T, Abe Y, Takahashi K, Igaki H, Itami J.

Pract Radiat Oncol. 2016 Nov - Dec;6(6):e361-e367. doi: 10.1016/j.prro.2016.01.008. Epub 2016 Jan 26.

PMID:
27053497

Supplemental Content

Support Center